These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17689338)

  • 21. Drug consumption rooms in rotterdam: an explorative description.
    van der Poel A; Barendregt C; van de Mheen D
    Eur Addict Res; 2003 Apr; 9(2):94-100. PubMed ID: 12644736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.
    Rhodes T; Kimber J; Small W; Fitzgerald J; Kerr T; Hickman M; Holloway G
    Addiction; 2006 Oct; 101(10):1384-93. PubMed ID: 16968336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harm Reduction: Front Line Public Health.
    Stancliff S; Phillips BW; Maghsoudi N; Joseph H
    J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK.
    Hunt N; Lloyd C; Kimber J; Tompkins C
    Int J Drug Policy; 2007 Jan; 18(1):62-5. PubMed ID: 17689345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug consumption rooms and the role of politics and governance in policy processes.
    Houborg E; Frank VA
    Int J Drug Policy; 2014 Sep; 25(5):972-7. PubMed ID: 24572642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks.
    Hyshka E; Anderson-Baron J; Karekezi K; Belle-Isle L; Elliott R; Pauly B; Strike C; Asbridge M; Dell C; McBride K; Hathaway A; Wild TC
    Harm Reduct J; 2017 Jul; 14(1):50. PubMed ID: 28747183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supervised inhalation is an important part of supervised consumption services.
    Bourque S; Pijl EM; Mason E; Manning J; Motz T
    Can J Public Health; 2019 Apr; 110(2):210-215. PubMed ID: 30725386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug consumption facilities: an update since 2000.
    Kimber J; Dolan K; van Beek I; Hedrich D; Zurhold H
    Drug Alcohol Rev; 2003 Jun; 22(2):227-33. PubMed ID: 12850909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How much can treatment reduce national drug problems?
    Reuter P; Pollack H
    Addiction; 2006 Mar; 101(3):341-7. PubMed ID: 16499507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug consumption rooms: A systematic review of evaluation methodologies.
    Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M
    Drug Alcohol Rev; 2019 May; 38(4):406-422. PubMed ID: 30938025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The initial experience in supervised injecting facilities in Denmark].
    Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
    Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fools rush in where angels fear to tread Playing God with Vancouver's Supervised Injection Facility in the political borderland.
    Small D
    Int J Drug Policy; 2007 Jan; 18(1):18-26. PubMed ID: 17689340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpharmacological harm-reduction interventions in British substance-misuse services.
    Rosenberg H; Melville J; McLean PC
    Addict Behav; 2004 Aug; 29(6):1225-9. PubMed ID: 15236827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug Consumption Rooms: Welfare State and Diversity in Social Acceptance in Denmark and in France.
    Houborg E; Jauffret-Roustide M
    Am J Public Health; 2022 Apr; 112(S2):S159-S165. PubMed ID: 35349316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supervised consumption rooms: the French Paradox.
    Jauffret-Roustide M; Pedrono G; Beltzer N
    Int J Drug Policy; 2013 Nov; 24(6):628-30. PubMed ID: 23777651
    [No Abstract]   [Full Text] [Related]  

  • 37. Providing health education on accidental drug overdose.
    Branagan O; Grogan L
    Nurs Times; 2006 Feb 7-13; 102(6):32-3. PubMed ID: 16494289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis.
    Parkin S; Coomber R
    Health Place; 2011 May; 17(3):717-26. PubMed ID: 21440483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Going soft on evidence and due process: Canada adopts US style harm maximization.
    Wodak A
    Int J Drug Policy; 2008 Jun; 19(3):226-8; discussion 233-4. PubMed ID: 18424112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.